Insider Transactions in Q3 2023 at Ligand Pharmaceuticals Inc (LGND)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 22
2023
|
Martine Zimmermann Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,285
+50.0%
|
-
|
|
Sep 22
2023
|
Todd C Davis Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+5.19%
|
$236,000
$59.38 P/Share
|
|
Aug 10
2023
|
Andrew Reardon CLO & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
897
-5.5%
|
$60,996
$68.73 P/Share
|